Venous Congestion and Acute Renal Failure in Cardiac Surgery Postoperative

NCT ID: NCT03013621

Last Updated: 2017-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-31

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute renal failure (ARF) is a frequent complication in the postoperative cardiac surgery, and is a major risk factor for mortality in this context.

The right ventricular dysfunction post cardiopulmonary bypass (CPB) is also a common complication, close to 100% if one takes into account the transient dysfunction.

A recent study showed that right ventricular dysfunction and the IRA seemed related, rather on the slope of venous congestion. We wish to study this phenomenon more specifically in particular to offer reliable diagnostic markers of venous congestion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Renal Failure (ARF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: all major patient
* Gender: both
* Subject has signed an informed consent
* IRA KDIGO stage 1 or urine output \<0.5 mL / kg / h for at least 6 hours / elevation creat\> 26.5μmol / L
* Patient in sinus rhythm at the time of the ultrasound measurements
* No diuretic since intervention
* Absence of circulatory failure (low doses of catecholamines tolerated)
* Extubated: absence of mechanical ventilation

Exclusion Criteria

* Chronic heart failure right
* Chronic renal failure (GFR \<60)
* Usual treatment with high dose diuretics (furosemide\> 40mg / day)
* Endocarditis
* Emergency surgery (aortic dissection, emergency bypass surgery) / heart surgery D / redux
* Circulatory Support
* ACFA / electro-paced rhythm
* Inability to give informed about information (subject in emergencies, understanding of the subject of difficulty, ...)
* Topic under judicial protection
* Topic guardianship or curatorship
* Pregnancy (women of childbearing age)
* Breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul-Michel MERTES, MD, PhD

Role: STUDY_DIRECTOR

University Hospital, Strasbourg, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service Réanimation chirurgicale cardio-vasculaire - NHC

Strasbourg, Strasbourg, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paul-Michel MERTES, MD, PhD

Role: CONTACT

33 3 69 55 15 78

Mircea CRISTINAR, MD

Role: CONTACT

33 3 69 55 12 65

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paul-Michel MERTES, MD, PhD

Role: primary

33 3 69 55 15 78

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6296

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vasoplegic Syndrome in Cardiac Surgery
NCT03281317 ACTIVE_NOT_RECRUITING